Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
Janet Hardy, Ristan M. Greer, Georgie Huggett, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 7, pp. 1444-1452
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 19
Cannabis-based medicines and medical cannabis for adults with cancer pain
Winfried Häuser, Patrick Welsch, Lukas Radbruch, et al.
Cochrane library (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 31
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies
Megan Crichton, Thusharika Dissanayaka, Wolfgang Marx, et al.
Maturitas (2024) Vol. 184, pp. 107941-107941
Open Access | Times Cited: 7
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 6
Has medicinal cannabis found a role in oncology/palliative care?
Janet Hardy, Phillip Good
Internal Medicine Journal (2025)
Closed Access
Relational approaches to conceptualising, measuring and enacting wellbeing and care in palliative and end-of-life contexts
Sarah Maslen, Rebecca E. Olson, Aileen Collier
Health Sociology Review (2025), pp. 1-7
Open Access
Management of Dyspnea in Advanced Cancer Patients: A Network Meta-Analysis of Pharmacological and Non-Pharmacological Interventions
Allison Vo, Kim-Ngan Ta-Thi, Kai-Jen Chuang
Asia-Pacific Journal of Oncology Nursing (2025) Vol. 12, pp. 100671-100671
Open Access
Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms
Andrew Moore, Sebastian Straube, Emma Fisher, et al.
Journal of Pain (2023) Vol. 25, Iss. 4, pp. 833-842
Open Access | Times Cited: 11
Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial
Taylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
The use of cannabinoids in palliating cancer-related symptoms: a narrative review
Jess Hatfield, Krishna Suthar, Tricia A. Meyer, et al.
Baylor University Medical Center Proceedings (2024) Vol. 37, Iss. 2, pp. 288-294
Open Access | Times Cited: 3
SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023)
Ainara Soria Rivas, Yolanda Escobar, Ana Blasco, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 11, pp. 2866-2876
Open Access | Times Cited: 3
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine
Magdalena Skórzewska, Katarzyna Gęca
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1334-1348
Open Access | Times Cited: 3
A provisional evaluation of Australia's medical cannabis program
Myfanwy Graham, Vivian Chiu, Daniel Stjepanović, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104210-104210
Open Access | Times Cited: 8
Should oncologists trust cannabinoids?
Ioana Creangă-Murariu, Leontina Elena Filipiuc, Magdalena Cuciureanu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
CBD-oil as a potential solution in case of severe tamoxifen-related side effects
Sanne M. Buijs, C. Louwrens Braal, Stefan A.J. Buck, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis
Alexandra Smith, Rebecca E. Olson, Nathalia Cordeiro da Costa, et al.
Sociology of Health & Illness (2023) Vol. 45, Iss. 8, pp. 1709-1729
Open Access | Times Cited: 4
Exploring potential anti-inflammatory effects of medicinal cannabis
Taylan Gurgenci, Gregor Kijanka, Ristan M. Greer, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 11
Open Access | Times Cited: 4
Should Cannabis be Used for Anorexia in Patients With Cancer?
Mellar P. Davis, Claude Cyr, Gregory B. Crawford, et al.
Journal of Pain and Symptom Management (2024) Vol. 67, Iss. 5, pp. e487-e492
Closed Access | Times Cited: 1
Should Subanesthetic Ketamine be Considered When Managing Opioid Refractory Cancer Pain?
Peter Poon, Rae Frances Bell, Phillip Good
Journal of Pain and Symptom Management (2024) Vol. 68, Iss. 2, pp. e146-e151
Closed Access | Times Cited: 1
Psychological distress and physical symptoms in advanced cancer: cross-sectional study
Bridget Podbury, Taylan Gurgenci, Georgie Huggett, et al.
BMJ Supportive & Palliative Care (2024), pp. spcare-004940
Closed Access | Times Cited: 1
Patient out-of-pocket costs for cannabis use during cancer treatment
Kaitlyn Lapen, Akriti Mishra Meza, Edward Christopher Dee, et al.
JNCI Monographs (2024) Vol. 2024, Iss. 66, pp. 305-312
Closed Access | Times Cited: 1
Cannabidiol for Scan-Related Anxiety in Women With Advanced Breast Cancer
Manan M. Nayak, Peter R. Chai, Paul J. Catalano, et al.
JAMA Network Open (2024) Vol. 7, Iss. 12, pp. e2450391-e2450391
Open Access | Times Cited: 1
Cannabidiol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis
Cian O’Leary, Ristan M. Greer, Georgie Huggett, et al.
BMJ Supportive & Palliative Care (2024) Vol. 14, Iss. 2, pp. 191-194
Closed Access
Pharmacodynamic effects following co-administration of cannabinoids and opioids: a scoping review of human experimental studies
David Guy, Jared C Wootten, Michael L. Wong, et al.
Pain Medicine (2024) Vol. 25, Iss. 7, pp. 423-434
Closed Access
Page 1 - Next Page

Scroll to top